Skip to content

ROOSEVELT INVESTMENT GROUP LLC: F position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ROOSEVELT INVESTMENT GROUP LLC on F, newest first. How the timeline and the estimate are built.

ROOSEVELT INVESTMENT GROUP LLC held 11,452 F shares at 2022-09-30 per its 13F-HR filed 2022-10-19.

the latest 13F is the newest step

  1. period ended2022-09-30
    13F 11,452 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $128,000.

    13F-HR 0001020617-22-000009 filed by ROOSEVELT INVESTMENT GROUP LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-06-30
    13F 11,452 shares
    Change vs previous 13F -11,377 shares

    0.01% of the 13F portfolio, value $127,000.

    13F-HR 0001020617-22-000007 filed by ROOSEVELT INVESTMENT GROUP LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2022-03-31
    13F 22,829 shares
    Change vs previous 13F +3,469 shares

    0.02% of the 13F portfolio, value $386,000.

    13F-HR 0001020617-22-000005 filed by ROOSEVELT INVESTMENT GROUP LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-12-31
    13F 19,360 shares
    Change vs previous 13F +6,217 shares

    0.02% of the 13F portfolio, value $402,000.

    13F-HR 0001020617-22-000002 filed by ROOSEVELT INVESTMENT GROUP LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-09-30
    13F 13,143 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $186,000.

    13F-HR 0001020617-21-000008 filed by ROOSEVELT INVESTMENT GROUP LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).